English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [9524]
News [23370]
Articles [1991]
Editorials [134]
Conferences [465]
elearning [298]
Bendamustine regimen more effective for lymphoma than standard CHOP
Dr Mathias Rummel - Universitaetsklinik, Giessen, Germany
Bendamustine regimen more effective for lymphoma than standard CHOP ( Dr Mathias Rummel - Universitaetsklinik, Giessen, Germany )
3 Jun 2012
Early results from new PD-1 targeted immune therapy
Dr Suzanne Topalian - Johns Hopkins University School of Medicine, Baltimore...
Early results from new PD-1 targeted immune therapy ( Dr Suzanne Topalian - Johns Hopkins University School of Medicine, Baltimore, USA )
2 Jun 2012
New study asks patients preference on kidney cancer treatment
Dr Bernard Escudier - Institut Gustave Roussy, Paris, France
New study asks patients preference on kidney cancer treatment ( Dr Bernard Escudier - Institut Gustave Roussy, Paris, France )
2 Jun 2012
Relapse and survival of adolescent and young adult leukaemia patients
Dr Eric Larsen - Maine Children’s Cancer Program, Scarborough, USA
Relapse and survival of adolescent and young adult leukaemia patients ( Dr Eric Larsen - Maine Children’s Cancer Program, Scarborough, USA )
2 Jun 2012
Adding bevacizumab to chemotherapy for platinum-resistant ovarian cancer...
Dr Eric Pujade-Lauraine - Université Paris Descartes, France
Adding bevacizumab to chemotherapy for platinum-resistant ovarian cancer improves progression-free survival ( Dr Eric Pujade-Lauraine - Université Paris Descartes, France )
2 Jun 2012
The Institute of Cancer Policy
Prof Richard Sullivan – Kings College, London, UK
The Institute of Cancer Policy ( Prof Richard Sullivan – Kings College, London, UK )
23 May 2012
The OECI and EurocanPlatform
Prof Wim van Harten – The Netherlands Cancer Institute, Amsterdam
The OECI and EurocanPlatform ( Prof Wim van Harten – The Netherlands Cancer Institute, Amsterdam )
21 May 2012
Problems in the structure of clinical trials
Prof Thomas Tursz – Institut Gustave Roussy, Paris, France
Problems in the structure of clinical trials ( Prof Thomas Tursz – Institut Gustave Roussy, Paris, France )
21 May 2012
Transfer of information through EurocanPlatform
Prof Ulrik Ringborg – Karolinska Institute, Stockholm, Sweden
Transfer of information through EurocanPlatform ( Prof Ulrik Ringborg – Karolinska Institute, Stockholm, Sweden )
21 May 2012
Prognostic biomarkers and next generation genomic sequencing
Prof Stefan Pfister – Cancer Research Centre, Heidelberg, Germany
Prognostic biomarkers and next generation genomic sequencing ( Prof Stefan Pfister – Cancer Research Centre, Heidelberg, Germany )
21 May 2012
Primary and secondary resistance in colorectal cancer
Dr Silvia Marsoni – The Institute for Cancer Research, Candiolo, Italy
Primary and secondary resistance in colorectal cancer ( Dr Silvia Marsoni – The Institute for Cancer Research, Candiolo, Italy )
21 May 2012
Analysing changes in the pharmaceutical industry
Dr Siegfried Bialojan – Ernst and Young, Germany
Analysing changes in the pharmaceutical industry ( Dr Siegfried Bialojan – Ernst and Young, Germany  )
21 May 2012
<1…686687688689690…794>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2026 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top